Literature DB >> 16447263

Growing importance of liver disease in HIV-infected persons.

David L Thomas1.   

Abstract

Liver disease is a growing problem in HIV-infected persons. In those who are able to take antiretroviral therapy, the forms of liver disease have changed and their relative importance has increased. This review focuses on liver disease in HIV-infected persons, caused by hepatitis C virus, hepatitis B virus, or treatment of HIV infection.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16447263     DOI： 10.1002/hep.21033

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  Nonalcoholic fatty liver disease and HIV infection.

Authors:  Raphael B Merriman
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

2.  Effects of liver disease on the well-being of persons living with HIV.

Authors:  Wendy A Henderson; Jane M Fall-Dickson; Elizabeth A Schlenk; Kevin H Kim; Judith T Matthews; Judith A Erlen
Journal:  J Assoc Nurses AIDS Care       Date:  2008 Sep-Oct       Impact factor: 1.354

Review 3.  Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment.

Authors:  Sarah M McCabe; Qing Ma; Judianne C Slish; Linda M Catanzaro; Neha Sheth; Robert DiCenzo; Gene D Morse
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.

Authors:  Gregory J Dore; Vicente Soriano; Jürgen Rockstroh; Bernd Kupfer; Ellen Tedaldi; Lars Peters; Jacqueline Neuhaus; Massimo Puoti; Marina B Klein; Amanda Mocroft; Bonaventura Clotet; Jens D Lundgren
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

5.  Hepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China.

Authors:  Yu Liu; Peibin Zeng; Jingxing Wang; Gui Liu; Min Xu; Ling Ke; Miao He; Zhong Liu
Journal:  J Transl Med       Date:  2014-06-12       Impact factor: 5.531

6.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

7.  Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China.

Authors:  Ya-Song Wu; Wei-Wei Zhang; Xue-Mei Ling; Lian Yang; Shao-Biao Huang; Xi-Cheng Wang; Hao Wu; Wei-Ping Cai; Min Wang; Hui Wang; Yan-Fen Liu; Hao-Lan He; Fei-Li Wei; Zun-You Wu; Fu-Jie Zhang
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.